Jennifer Buell, President and Chief Executive Officer at MiNK Therapeutics, shared on X:
“Live now at ESMO26: OncoDaily spotlights sarcoma and launches OncoDaily Sarcoma.
Prof. Robin Jones mandates faster progress and ‘clever designs’ to expand options. Points to iNKT–myeloid crosstalk MiNK Therapeutics may broaden activity?”
Read also: OncoDaily Grand Rounds at ESMO 2026: Sarcoma Edition
